Pharmacological Potential of Nigella Sativa in Metabolic, Inflammatory, and Neurological Disorders: A Comprehensive Review from an Unani Perspective
Authors
PG Scholars, Dept. of Moalajat, Government Unani Medical College, Chennai, Tamil Nadu (India)
Prof & HOD, Department of Moalajat, Government Unani Medical College, Chennai, Tamil Nadu (India)
Prof &HOD, Department of Ilmul Advia, Government Unani Medical College, Chennai, Tamil Nadu (India)
PG Scholars, Dept. of Moalajat, Government Unani Medical College, Chennai, Tamil Nadu (India)
PG scholar, department of Ilmul advia, Government Unani Medical College, Chennai, Tamil Nadu (India)
Article Information
DOI: 10.51584/IJRIAS.2026.11060105
Subject Category: Pharmaceutics
Volume/Issue: 11/6 | Page No: 1293-1303
Publication Timeline
Submitted: 2026-06-03
Accepted: 2026-06-08
Published: 2026-06-26
Abstract
Nigella sativa (NS) is a plant extensively used for its therapeutic properties. NS is also termed as Kalonji, Black seed, or black cumin. In Unani medicine, it has properties of Muhallil-i-waram (anti-inflammatory), Mudirr-i-Bawl (diuretic), Mufattiḥ-i-Sudad (deobstruent), and Muqawwī-i-A‘ṣāb (nervine tonic). It has been used for inflammatory, metabolic, respiratory, and neurological disorders. This review aims to provide a detailed description of Kalonji (NS) in the Unani System of Medicine and to critically evaluate the pharmacological potential of Nigella sativa in metabolic, inflammatory, neurological, and respiratory diseases, especially from an Unani perspective. We performed a literature search using various keywords such as Nigella sativa from the year 2020 to 2026 with the help of PubMed and Google Scholar databases for different therapeutic activities of this plant, focusing on antidiabetic, thymoquinone, anti-inflammatory, antioxidant, and neuroprotective properties, etc. It has a significant potential role to modulate neuronal functions, glycaemic control, inflammatory pathways, and oxidative stress based on experimental as well as clinical findings. Despite this current potential for therapeutic efficacy, the evidence today is largely from preclinical studies, and large-scale standardized clinical trials are lacking. More research is warranted to determine safety, efficacy, dosage standardization, and chronic therapeutic use of integrative medicine.
Keywords
Kalonji, Nigella sativa, Thymoquinone, Unani medicine, Anti-inflammatory
Downloads
References
1. Hannan MdA, Rahman MdA, Sohag AAM, Uddin MdJ, Dash R, Sikder MH, et al. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety. Nutrients. 2021 May 24;13(6):1784. doi:10.3390/nu13061784 [Google Scholar] [Crossref]
2. Ghaznavi, K. M., 1991. Tibb-e-Nabvi aur Jadid Science, Al-Faisal Nasheeran Wa Tajeeran-e-Kutub. Urdu Bazar Lahore, Pakistan. 1: 228-236. In. [Google Scholar] [Crossref]
3. Douglas Harper 2001-2015 “Online Etymology Dictionary” http://www.etymonline.com. In. [Google Scholar] [Crossref]
4. Rizwan, Syed & Hussain, Syeda & Ahsan, Syeda & Ashfaq, Mehak & Bano, Shumla & Akhlaq, Muhammad. (2022). Black Seeds (Nigella Satival.) -kalonji: A Brief Review of its Anti-Cancer and Anti- Tumour Qualities. Hamdard Medicus. 65. 2022. [Google Scholar] [Crossref]
5. Zohary D, Hopf M, and Weiss E, Domestication of Plants in the Old World: The Origin and Spread of Domesticated Plants in Southwest Asia, Europe, and the Mediterranean Basin, Oxford University Press on Demand, 2012. [Google Scholar] [Crossref]
6. Naz, Hajra. (2011). Nigella sativa: The miraculous herb. Pak. J. Biochem. Mol Biol. 44. 44-48. [Google Scholar] [Crossref]
7. Gholamnezhad, Z., Havakhah, S., Boskabady, M.H., 2016. Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: a review. J. Ethnopharmacol. 190, 372–386. [Google Scholar] [Crossref]
8. Ahmad MF, Ahmad FA, Ashraf SA, Saad HH, Wahab S, Khan MI, et al. An updated knowledge of Black seed (Nigella sativa Linn.): Review of phytochemical constituents and pharmacological properties. Journal of Herbal Medicine. 2021 Feb;25:100404. doi:10.1016/j.hermed.2020.100404 [Google Scholar] [Crossref]
9. Najmul Ghani 1920; “Khazaynul Adviya” Vol. - III, Sheikh Bashir & Sons, Lahore, Pakistan, p 388-91. In. [Google Scholar] [Crossref]
10. Kabiruddin M.1935; “Biyaze Kabir” Vol.-III, Shaukat Book Depo, Gujrat, Pakistan, p 15-20. In. [Google Scholar] [Crossref]
11. Ibne Baiytar 1248; “Aljame Almufredat Aladviya Wal Aghziya”Vol. - III, Urdu Translation by CCRUM, New Delhi, p 156-58. In. [Google Scholar] [Crossref]
12. Hakeem A.1311 H; “Bustanul Mufredat” Zafar Book Depo, Delhi p 258. [Google Scholar] [Crossref]
13. Anonymous 2007; “Unani Pharmacopoeia of India” Part I, Vol.- I, Department of AYUSH, New Delhi p 42-43. In. [Google Scholar] [Crossref]
14. Khare CP. Indian medicinal plants. Printed in New Delhi: Springer science + business Media Ltd, 2007, 439. [Google Scholar] [Crossref]
15. Kabiruddin. Makhzanulmufradat. Lahore: publication Siddiqui, 461. [Google Scholar] [Crossref]
16. Anonymous. The Unani Pharmacopoeia Of India (First Edition) .Ministry Of Health & Family Welfare Government Of India. YNM. [Google Scholar] [Crossref]
17. Sina I. Alqanoon Fit Tib. Book 3rd, Vol 1(Arabic), IHMMR Jamia Hamdard, New Delhi: 1981,p152-153,128-154. [Google Scholar] [Crossref]
18. S. VT, S. F, B. HM, D. MS. A review on therapeutic potential of Nigella sativa (kalonji) seeds. J Med Plants Res. 2014 Jan 17;8(3):167–77. doi:10.5897/JMPR10.737 [Google Scholar] [Crossref]
19. Rajkapoor, B., Anandan, R., Jayakar, B., 2002. Antiulcer effect of Nigella sativa Linn. against gastric ulcer in rats. Curr. Sci. 82, 177–179. [Google Scholar] [Crossref]
20. Talebi M, Talebi M, Farkhondeh T, Samarghandian S. Biological and therapeutic activities of thymoquinone: Focus on the Nrf2 signaling pathway. Phytotherapy Research. 2021;35:1739–1753. https://doi.org/10.1002/ptr.6905. [Google Scholar] [Crossref]
21. Ahmad MF, Ahmad FA, Ashraf SA, Saad HH, Wahab S, Khan MI, et al. An updated knowledge of Black seed (Nigella sativa Linn.): Review of phytochemical constituents and pharmacological properties. Journal of Herbal Medicine. 2021 Feb;25:100404. doi:10.1016/j.hermed.2020.100404 [Google Scholar] [Crossref]
22. de Oliveira TM, de Carvalho RB, da Costa IH, de Oliveira GA, de Souza AA, de Lima SG, de Freitas RM. Evaluation of p-cymene, a natural antioxidant. Pharm Biol. 2015 Mar;53(3):423-8. doi: 10.3109/13880209.2014.923003. Epub 2014 Dec 4. PMID: 25471840. [Google Scholar] [Crossref]
23. de Carvalho FO, Silva ÉR, Gomes IA, et al. Anti-inflammatory and antioxidant activity of carvacrol in the respiratory system: A systematic review and meta-analysis. Phytotherapy Research. 2020;34:2214–2229. https://doi.org/10.1002/ptr.6688. [Google Scholar] [Crossref]
24. Wang G, Wang Y, Yao L, Gu W, Zhao S, Shen Z, et al. Pharmacological Activity of Quercetin: An Updated Review. Cohen G, editor. Evidence-Based Complementary and Alternative Medicine. 2022 Dec 1;2022:1–12. doi:10.1155/2022/3997190 [Google Scholar] [Crossref]
25. Maiti S, Banerjee A, Nazmeen A, Kanwar M, Das S. Active-site molecular docking of nigellidine with nucleocapsid-NSP2-MPro of COVID-19 and to human IL1R-IL6R and strong antioxidant role of Nigella sativa in experimental rats. J Drug Target. 2022 Jun;30(5):511-521. doi: 10.1080/1061186X.2020.1817040. Epub 2022 Mar 18. PMID: 32875925. [Google Scholar] [Crossref]
26. Fallahi M, Keyhanmanesh R, Khamaneh AM, Ebrahimi Saadatlou MA, Saadat S, Ebrahimi H. Effect of Alpha-Hederin, the active constituent of Nigella sativa, on miRNA-126, IL-13 mRNA levels and inflammation of lungs in ovalbumin-sensitized male rats. Avicenna J Phytomed. 2016 Jan-Feb;6(1):77-85. PMID: 27247924; PMCID: PMC4884220. [Google Scholar] [Crossref]
27. Hadi S, Daryabeygi-Khotbehsara R, Mirmiran P, McVicar J, Hadi V, Soleimani D, Askari G. Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial. Phytother Res. 2021 Jul;35(7):3747-3755. doi: 10.1002/ptr.6990. Epub 2021 Jun 17. PMID: 34142392. [Google Scholar] [Crossref]
28. Amirtaheri Afshar A, Toopchizadeh V, Dolatkhah N, Jahanjou F, Farshbaf‐Khalili A. The efficacy of Nigella sativa L. oil on serum biomarkers of inflammation and oxidative stress and quality of life in patients with knee osteoarthritis: A parallel triple‐arm double‐blind randomized controlled trial. Food Science & Nutrition. 2023 Dec;11(12):7910–20. doi:10.1002/fsn3.3708 [Google Scholar] [Crossref]
29. Lan X, Xia Y. Alleviating effects of Nigella sativa supplements on biomarkers of inflammation and oxidative stress: Results from an umbrella meta-analysis. Prostaglandins & Other Lipid Mediators. 2025 Jan 1;176:106945. doi:10.1016/j.prostaglandins.2024.106945 [Google Scholar] [Crossref]
30. Han A, Shi D. The efficacy of Nigella sativa supplementation for asthma control: a meta-analysis of randomized controlled studies. Postepy Dermatol Alergol. 2021 Aug;38(4):561–5. doi:10.5114/ada.2020.93220 PubMed PMID: 34658694; PubMed Central PMCID: PMC8501420. [Google Scholar] [Crossref]
31. Saadat S, Aslani MR, Ghorani V, Keyhanmanesh R, Boskabady MH. The effects of Nigella sativa on respiratory, allergic and immunologic disorders, evidence from experimental and clinical studies, a comprehensive and updated review. Phytother Res. 2021 Jun;35(6):2968-2996. doi: 10.1002/ptr.7003. Epub 2021 Jan 17. PMID: 33455047. [Google Scholar] [Crossref]
32. He Y, Hu X, Chang L, Liu S, Lv L, Qin G, et al. Meta-analysis of randomized controlled trials assessing the efficacy of nigella sativa supplementation for allergic rhinitis treatment. Front Pharmacol. 2024 Sep 20;15:1417013. doi:10.3389/fphar.2024.1417013 [Google Scholar] [Crossref]
33. Karimi M, Pirzad S, Pourfaraji SMA, Sedgi FM, Darouei B, Amani-Beni R, et al. Effects of black seed (Nigella sativa L.) on cardiometabolic indices in type 2 diabetic patients: A systematic review and meta-analysis of RCTs. Complementary Therapies in Medicine. 2025 Jun;90:103174. doi:10.1016/j.ctim.2025.103174 [Google Scholar] [Crossref]
34. Elibol B, Beker M, Terzioglu-Usak S, Dalli T, Kilic U. Thymoquinone administration ameliorates Alzheimer’s disease-like phenotype by promoting cell survival in the hippocampus of amyloid beta1-42 infused rat model. Phytomedicine. 2020 Dec;79:153324. doi: 10.1016/j.phymed.2020.153324. Epub 2020 Sep 1. PMID: 32920292. [Google Scholar] [Crossref]
35. Khan FZ, Mostaid MS, Apu MNH. Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease. Heliyon. 2022 Jul 5;8(7):e09874. doi: 10.1016/j.heliyon.2022.e09874. PMID: 35832342; PMCID: PMC9272348. [Google Scholar] [Crossref]
36. Sedaghat R, Roghani M, Khalili M. Neuroprotective effect of thymoquinone, the nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model. Iran J Pharm Res. 2014 Winter;13(1):227-34. PMID: 24734075; PMCID: PMC3985249. [Google Scholar] [Crossref]
37. Akhondian J, Kianifar H, Raoofziaee M, Moayedpour A, Toosi MB, Khajedaluee M. The effect of thymoquinone on intractable pediatric seizures (pilot study). Epilepsy Research. 2011 Jan 1;93(1):39–43. doi:10.1016/j.eplepsyres.2010.10.010 [Google Scholar] [Crossref]
38. Ojetunde AO, Alhassan A, Suleiman I, Isa AS. Nigella Sativa Oil Protects Against Aluminium Chloride-Induced Cognitive Impairment Via Modulation of Cholinergic Activity, Brain Neurotransmitter, and Oxidative Stress. BIOMEDNATPROCH. 2025 Oct 1;14(2):739–46. doi:10.14421/biomedich.2025.142.739-746 [Google Scholar] [Crossref]
Metrics
Views & Downloads
Similar Articles
- Development and Evaluation of Floating Alginate Beads of Esomeprazole
- Determination of pKa Value for Ranolazine and Atenolol Using UV Spectroscopy
- The Science of Sustained-Release Medications
- Development of Proteomics in Clinical Medicine
- Advances on Quinoline Derivatives: A Review of Synthesis and Biological Activities